Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

axcelis technologies - ACLS

ACLS

Close Chg Chg %
81.55 -1.21 -1.48%

Open Market

80.34

-1.21 (1.48%)

Volume: 217.21K

Last Updated:

Dec 31, 2025, 4:00 PM EDT

Trade Now

Company Overview: axcelis technologies - ACLS

ACLS Key Data

Open

$81.64

 Day Range

80.04 - 81.64

52 Week Range

40.40 - 102.93

 Market Cap

$2.49B

Shares Outstanding

31.00M

 Public Float

30.56M

Beta

1.73

 Rev. Per Employee

N/A

P/E Ratio

19.28

 EPS

$4.24

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

481.89K

  

ACLS Performance

1 Week
 
 -2.75%
 
1 Month
 
 -2.94%
 
3 Months
 
 -9.44%
 
1 Year
 
 14.98%
 
5 Years
 
 175.89%
 

ACLS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About axcelis technologies - ACLS

Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.

ACLS At a Glance

Axcelis Technologies, Inc.
108 Cherry Hill Drive
Beverly, Massachusetts 01915-1088
Phone 1-978-787-4000 Revenue 1.02B
Industry Industrial Machinery Net Income 200.99M
Sector Producer Manufacturing Employees 1,524
Fiscal Year-end 12 / 2025
View SEC Filings

ACLS Valuation

P/E Current 19.34
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.369
Price to Sales Ratio 2.245
Price to Book Ratio 2.233
Price to Cash Flow Ratio 16.23
Enterprise Value to EBITDA 7.887
Enterprise Value to Sales 1.756
Total Debt to Enterprise Value 0.041

ACLS Efficiency

Revenue/Employee 667,890.42
Income Per Employee 131,884.514
Receivables Turnover 5.01
Total Asset Turnover 0.774

ACLS Liquidity

Current Ratio 5.414
Quick Ratio 4.054
Cash Ratio 2.753

ACLS Profitability

Gross Margin 44.667
Operating Margin 20.709
Pretax Margin 22.623
Net Margin 19.746
Return on Assets 15.28
Return on Equity 21.409
Return on Total Capital 18.503
Return on Invested Capital 19.952

ACLS Capital Structure

Total Debt to Total Equity 7.254
Total Debt to Total Capital 6.763
Total Debt to Total Assets 5.447
Long-Term Debt to Equity 6.68
Long-Term Debt to Total Capital 6.228
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Axcelis Technologies - ACLS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
662.43M 920.00M 1.13B 1.02B
Sales Growth
+39.59% +38.88% +22.89% -9.97%
Cost of Goods Sold (COGS) incl D&A
372.23M 518.21M 639.30M 563.21M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
10.82M 11.61M 13.07M 15.81M
Depreciation
10.82M 11.61M 13.07M 15.81M
Amortization of Intangibles
- - - -
-
COGS Growth
+36.71% +39.22% +23.37% -11.90%
Gross Income
290.20M 401.79M 491.30M 454.65M
Gross Income Growth
+43.46% +38.45% +22.28% -7.46%
Gross Profit Margin
+43.81% +43.67% +43.45% +44.67%
2021 2022 2023 2024 5-year trend
SG&A Expense
159.12M 189.43M 225.51M 243.86M
Research & Development
65.43M 78.36M 96.91M 105.50M
Other SG&A
93.69M 111.07M 128.60M 138.36M
SGA Growth
+13.22% +19.05% +19.05% +8.14%
Other Operating Expense
- - - 3.75M
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
127.33M 212.36M 265.80M 210.79M
Non Operating Income/Expense
(2.06M) (1.90M) 18.15M 24.94M
Non-Operating Interest Income
209.00K 4.55M 18.20M 24.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.83M 5.58M 5.35M 5.46M
Interest Expense Growth
-7.22% +15.33% -4.11% +2.15%
Gross Interest Expense
4.83M 5.58M 5.35M 5.46M
Interest Capitalized
- - - -
-
Pretax Income
120.43M 204.88M 278.60M 230.27M
Pretax Income Growth
+115.49% +70.13% +35.98% -17.35%
Pretax Margin
+18.18% +22.27% +24.64% +22.62%
Income Tax
21.78M 21.81M 32.34M 29.28M
Income Tax - Current - Domestic
82.00K 10.15M 48.86M 40.99M
Income Tax - Current - Foreign
1.44M 3.12M 3.50M 3.89M
Income Tax - Deferred - Domestic
20.93M 8.99M (18.97M) (13.55M)
Income Tax - Deferred - Foreign
(670.00K) (459.00K) (1.05M) (2.04M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
98.65M 183.08M 246.26M 200.99M
Minority Interest Expense
- - - -
-
Net Income
98.65M 183.08M 246.26M 200.99M
Net Income Growth
+97.37% +85.58% +34.51% -18.38%
Net Margin Growth
+14.89% +19.90% +21.78% +19.75%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
98.65M 183.08M 246.26M 200.99M
Preferred Dividends
- - - -
-
Net Income Available to Common
98.65M 183.08M 246.26M 200.99M
EPS (Basic)
2.94 5.5406 7.5176 6.1745
EPS (Basic) Growth
+95.62% +88.46% +35.68% -17.87%
Basic Shares Outstanding
33.55M 33.04M 32.76M 32.55M
EPS (Diluted)
2.8788 5.4582 7.4254 6.1458
EPS (Diluted) Growth
+96.56% +89.60% +36.04% -17.23%
Diluted Shares Outstanding
34.27M 33.54M 33.16M 32.70M
EBITDA
138.14M 223.97M 278.86M 226.60M
EBITDA Growth
+103.21% +62.13% +24.51% -18.74%
EBITDA Margin
+20.85% +24.34% +24.67% +22.26%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 96.80
Number of Ratings 8 Current Quarters Estimate 1.053
FY Report Date 03 / 2026 Current Year's Estimate 4.543
Last Quarter’s Earnings 1.12 Median PE on CY Estimate N/A
Year Ago Earnings 4.463 Next Fiscal Year Estimate 4.53
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 8 1
Mean Estimate 1.05 1.09 4.54 4.53
High Estimates 1.17 1.23 5.00 4.53
Low Estimate 0.81 0.99 3.95 4.53
Coefficient of Variance 11.80 7.86 7.96 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 2
OVERWEIGHT 0 0 0
HOLD 4 4 6
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Hold

Insider Actions for Axcelis Technologies - ACLS

Date Name Shares Transaction Value
May 21, 2025 Russell J. Low PRESIDENT AND CEO; Director 137,142 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $61.58 per share 8,445,204.36
May 21, 2025 Russell J. Low PRESIDENT AND CEO; Director 136,155 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.01 per share 8,442,971.55
May 21, 2025 Greg Redinbo EVP MARKETING AND APPLICATIONS 33,603 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $61.58 per share 2,069,272.74
May 20, 2025 Greg Redinbo EVP MARKETING AND APPLICATIONS 33,970 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 2,128,899.90
May 20, 2025 Christopher Tatnall EVP Global Customer Operations 24,441 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 1,531,717.47
May 20, 2025 Christopher Tatnall EVP Global Customer Operations 24,611 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 1,542,371.37
May 20, 2025 Christopher Tatnall EVP Global Customer Operations 24,956 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 Christopher Tatnall EVP Global Customer Operations 18,808 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 Gerald M Blumenstock EVP, Research, Dev. & Eng. 22,201 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 1,391,336.67
May 20, 2025 Gerald M Blumenstock EVP, Research, Dev. & Eng. 22,546 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 Gerald M Blumenstock EVP, Research, Dev. & Eng. 16,398 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 Greg Redinbo EVP MARKETING AND APPLICATIONS 33,793 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 2,117,807.31
May 20, 2025 James G. Coogan EVP AND CFO 27,936 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 Greg Redinbo EVP MARKETING AND APPLICATIONS 34,179 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 Russell J. Low PRESIDENT AND CEO; Director 137,854 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 8,639,310.18
May 20, 2025 Russell J. Low PRESIDENT AND CEO; Director 139,307 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 8,730,369.69
May 20, 2025 James G. Coogan EVP AND CFO 39,657 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share 2,485,304.19
May 20, 2025 James G. Coogan EVP AND CFO 40,231 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Axcelis Technologies in the News